NDC 0049-3170 Vfend
Voriconazole Tablet, Film Coated Oral
|Color(s)||WHITE (C48325) |
|Shape||ROUND (C48348) |
|Size(s)||7 MM |
NDC Code 0049-3170-30
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE
What is NDC 0049-3170?
The NDC code 0049-3170 is assigned by the FDA to the product Vfend which is a human prescription drug product labeled by Roerig. The generic name of Vfend is voriconazole. The product's dosage form is tablet, film coated and is administered via oral form. The product is distributed in a single package with assigned NDC code 0049-3170-30 30 tablet, film coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
What are the uses for Vfend?
Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.
What are Vfend Active Ingredients?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- VORICONAZOLE 50 mg/1 - A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
Which are Vfend UNII Codes?
The UNII codes for the active ingredients in this product are:
- VORICONAZOLE (UNII: JFU09I87TR)
- VORICONAZOLE (UNII: JFU09I87TR) (Active Moiety)
Which are Vfend Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
What is the NDC to RxNorm Crosswalk for Vfend?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 349434 - voriconazole 200 MG Oral Tablet
- RxCUI: 349435 - voriconazole 50 MG Oral Tablet
- RxCUI: 351209 - voriconazole 200 MG Injection
- RxCUI: 352218 - Vfend 50 MG Oral Tablet
- RxCUI: 352218 - voriconazole 50 MG Oral Tablet [Vfend]
Which are the Pharmacologic Classes for Vfend?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the disclaimer below.
Voriconazole is used in adults and children 2 years of age and older to treat serious fungal infections such as invasive aspergillosis (a fungal infection that begins in the lungs and spreads through the bloodstream to other organs), esophageal candidiasis (a yeast [a type of fungus] infection that may cause white patching in the mouth and throat), and candidemia (a fungal infection in the blood). It is also used to treat certain other fungal infections when other medications will not work for certain patients. Voriconazole is in a class of antifungal medications called triazoles. It works by slowing the growth of the fungi that cause infection.
* Please review the disclaimer below.
We have moved the product label and warning information to a dedicated page, please follow the link below:View Product Label